PROMIS NEUROSCIENCES INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
PROMIS NEUROSCIENCES INC. (PMN) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 20.88 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2026-03-25
- PROMIS NEUROSCIENCES INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2024 was 20.88K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | 20.88K shares 10-K · filed 2026-03-25 | 522.05K shares 10-K · filed 2025-03-31 | |
| 2024-09-30 | 696.07K shares 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |